Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-02

Clinical Trial Update: Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial compared adding Niravam (alprazolam) to an SSRI or SNRI versus SSRI or SNRI alone in generalized anxiety disorder or panic disorder; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niravam (alprazolam)

Snippet

Sponsor: UCB Pharma | Conditions: Generalized Anxiety Disorder, Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2009-10-02